Why is Warner Bros. Discovery splitting into two companies?
How will US-China trade talks in London impact markets?
What caused Bitcoin transaction activity to hit a low?
Why did Trump deploy National Guard to Los Angeles protests?
How will OpenAI’s $10B revenue milestone affect AI industry?
What are the implications of Apple’s WWDC 2025 redesign?
Why did Tesla receive stock downgrades amid Musk-Trump feud?
Merck's Cholesterol Lowering Drug Hits Primary Goal In Two Pivotal Trials
benzinga.com/news/health-care/25/06/45845078/mercks-cholesterol-lowering-drug-hits-primary-goal-in-two-pivotal-trials
Merck & Co., Inc. (NYSE:MRK) on Monday shared topline results from the first two of three Phase 3 clinical trials evaluating the safety and efficacy of enlicitide decanoate, an investigational, oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor for hyperlipidemia on…
This story appeared on benzinga.com, 2025-06-09 18:15:01.